XML 70 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Statutory and other information (Tables)
12 Months Ended
Mar. 31, 2021
Disclosure of transactions between related parties [line items]  
Schedule of statutory and other information

 

 

 

 

 

 

 

20. Statutory and other information

 

Year ended

 

 

March 31, 

 

     

2021

     

2020

     

2019

 

 

€M

 

€M

 

€M

Directors’ emoluments:

 

 

 

 

 

 

-Fees

 

0.5

 

0.6

 

0.7

-Share based compensation

 

1.9

 

2.7

 

1.9

-Other emoluments

 

0.3

 

0.9

 

1.8

Total Directors’ emoluments

 

2.7

 

4.2

 

4.4

Auditor’s remuneration (including reimbursement of outlay):

 

 

 

 

 

 

- Audit fees (i)

 

0.6

 

0.7

 

0.5

- Audit related fees (ii)

 

0.1

 

 —

 

 —

- Tax advisory fees (iii)

 

0.1

 

0.2

 

0.2

Total fees

 

0.8

 

0.9

 

0.7

Included within the above total fees, the following fees were payable to other KPMG firms outside of Ireland:

 

 

 

 

 

 

- Audit fees (i)

 

0.1

 

0.1

 

0.1

- Audit related fees (ii)

 

 —

 

 —

 

 —

- Tax advisory fees (iii)

 

 —

 

0.1

 

0.1

Total fees

 

0.1

 

0.2

 

0.2

Depreciation of owned property, plant and equipment

 

496.5

 

683.5

 

633.4

Depreciation of property, plant and equipment held under finance leases

 

5.9

 

5.9

 

7.1

Lease charges, principally for aircraft (iv)

 

6.7

 

38.2

 

83.9

 

(i)

Audit fees comprise audit work performed on the consolidated financial statements, including statutory financial statements of subsidiary entities. In fiscal year 2021 €1,000 (2020: €1,000; 2019: €1,000) of audit fees relate to the audit of the Parent Company.

(ii)

Audit related fees comprise fees for assurance and services related to audit and other attestation services performed by KPMG as required by statute, regulation or contract and which are not reported under “Audit fees”.

(iii)

Tax fees include all services, except those services specifically related to the audit of financial statements, performed by the independent auditor’s tax personnel, supporting tax-related regulatory requirements, and tax compliance and reporting.

(iv)

Lease charges relates to leases with a duration of less than 12 months for which the Company availed of the short-term lease exemption under IFRS 16.

Schedule of beneficial interests held by directors, of their spouses and dependent children in office

 

 

 

 

 

 

 

 

 

No. of Shares at March 31, 

 

    

2021

    

2020

    

2019

Michael Cawley

 

756,198

 

756,198

 

756,198

Emer Daly

 

6,840

 

3,260

 

3,260

Stan McCarthy

 

10,000

 

10,000

 

10,000

Howard Millar

 

435,000

 

390,000

 

390,000

Dick Milliken

 

9,750

 

9,750

 

9,750

Mike O'Brien

 

4,405

 

 —

 

 —

Michael O’Leary

 

44,096,725

 

44,096,725

 

44,096,725

Julie O'Neill

 

5,000

 

1,000

 

1,000

Louise Phelan

 

30,000

 

30,000

 

30,000

 

Schedule of share options held by director in office

 

 

 

 

 

 

 

 

 

No. of Options at March 31, 

 

    

2021

    

2020

    

2019

Róisín Brennan (d)

 

50,000

 

50,000

 

50,000

Michael Cawley (a) (d)

 

80,000

 

80,000

 

80,000

Emer Daly (d)

 

50,000

 

50,000

 

50,000

Stan McCarthy (d)

 

50,000

 

50,000

 

50,000

Howard Millar (c) (d)

 

50,000

 

80,000

 

80,000

Dick Milliken (a) (d)

 

80,000

 

80,000

 

80,000

Mike O'Brien (d)

 

50,000

 

50,000

 

50,000

Michael O’Leary (b) (e)

 

15,000,000

 

15,000,000

 

15,000,000

Julie O’Neill (a) (d)

 

50,000

 

80,000

 

80,000

Louise Phelan (a) (d)

 

80,000

 

80,000

 

80,000

 

(a)

30,000 options were granted to these Directors at an exercise price of €6.25 (the market value at the date of grant) during fiscal year 2015, these options vested in May 2019.

(b)

5,000,000 options were granted to Mr.O’Leary during fiscal year 2015 at an exercise price of €8.35 (the market value at the date of grant), these options vested in July 2019.

(c)

30,000 options were granted to this Director at an exercise price of €11.38 (the market price at the date of grant) during fiscal year 2016, these options vested in May 2019.

(d)

50,000 options were granted to these Directors at an exercise price of €11.12 (the market value at the date of grant) during fiscal year 2019. These options are exercisable subject to the Director still being a Non-Executive Director of the Company through July 31, 2024.

(e)

10,000,000 options were granted to Mr. O’Leary at an exercise price of €11.12 (the market value at the date of grant) during fiscal year 2019. These options are exercisable subject to him still being an employee of the Ryanair Group through July 31, 2024.

 

Michael O Leary  
Disclosure of transactions between related parties [line items]  
Schedule of fees and emoluments

 

 

 

 

 

 

 

(a)  Fees and emoluments - Executive Director

 

Year ended

 

 

March 31, 

 

     

2021

     

2020

     

2019

 

 

€M

 

€M

 

€M

Basic salary

 

0.25

 

0.50

 

1.06

Bonus (performance and target-related)

 

 —

 

0.46

 

0.77

Share based compensation (i)

 

1.78

 

2.51

 

1.55

 

 

2.03

 

3.47

 

3.38

 

(i)

2020 and 2021 include €1.78m non-cash accounting charge for 10m share options granted under the Group CEO’s new 5-year contract in February 2019. The remaining charge in 2020 and 2019 relates to share options that vested in 2019.

Non-executive director  
Disclosure of transactions between related parties [line items]  
Schedule of fees and emoluments

 

 

 

 

 

 

 

(b)  Fees and emoluments – Non-Executive Directors

 

Year ended

 

 

March 31, 

 

     

2021

     

2020

     

2019

 

 

€'000

 

€'000

 

€'000

Fees

 

 

 

 

 

 

David Bonderman (i)

 

16.7

 

100.0

 

100.0

Róisín Brennan (ii)

 

45.8

 

50.0

 

40.0

Michael Cawley

 

45.8

 

50.0

 

50.0

Emer Daly

 

45.8

 

50.0

 

50.0

Stan McCarthy (iii)

 

87.5

 

50.0

 

50.0

Charles McCreevy (iv)

 

 -

 

 -

 

30.0

Declan McKeon (v)

 

 -

 

 -

 

30.0

Kyran McLaughlin (i)

 

11.9

 

50.0

 

50.0

Howard Millar

 

45.8

 

50.0

 

50.0

Dick Milliken

 

45.8

 

50.0

 

50.0

Mike O’Brien

 

68.8

 

80.0

 

80.0

Julie O’Neill

 

45.8

 

50.0

 

50.0

Louise Phelan

 

45.8

 

50.0

 

50.0

 

 

505.5

 

630.0

 

680.0

Emoluments

 

 

 

 

 

 

Share based compensation

 

83.1

 

150.0

 

290.0

Total

 

588.6

 

780.0

 

970.0

 

(i)

David Bonderman and Kyran McLaughlin retired from the Board of Directors on May 31, 2020.

(ii)

Róisín Brennan was appointed to the Board of Directors in May 2018.

(iii)

Stan McCarthy was appointed Chairman from June 1, 2020.

(iv)

Charles McCreevy retired from the Board of Directors in September 2018.

(v)

Declan McKeon retired from the Board of Directors in September 2018.